Browsing by Author Cornberg, M

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 1 to 18 of 18
TitleAuthor(s)Issue Date
 
Assay for Hepatitis B Core-related Antigen Identify Patients With High Viral Load: Systematic Review and Meta-analysis of Individual Participant Data
Journal:Clinical Gastroenterology and Hepatology
Yoshida, KDesbiolles, AFeldman, SFAhn, SHAlidjinou, EKAtsukawa, MBocket, LBrunetto, MRButi, MCarey, ICaviglia, GPChen, EQCornberg, MEnomoto, MHonda, MZu Siederdissen, CHIshigami, MJanssen, HLAMaasoumy, BMatsui, TMatsumoto, ANishiguchi, SRiveiro-Barciela, MTakaki, ATangkijvanich, PToyoda, Hvan Campenhout, MJHWang, BWe, LYang, HIYano, YYatsuhashi, HYuen, MFTanaka, ELemoine, MTanaka, YShimakawa, Y
2020
 
Differential patterns of virological relapse and remission after discontinuation of tenofovir disoproxil fumarate or entecavir: results from a global, multi-ethnic cohort of patients with chronic hepatitis B virus infection (RETRACT-B Study)
Proceeding/Conference:Poster presentation at the AASLD The Liver Meeting, November 12-15. 2021. Hepatology
Choi, HSJHirode, GChen, CHSu, T-HWong, GLHSeto, WKWHees, SVPapatheodoridi, MBrakenhoff, SLens, SSarowar, AChien, R-NFeld, JJForns, XSonneveld, MJPapatheodoridis, GVanwolleghem, TYuen, RMFChan, HLYKao, J-HHsu, Y-CCornberg, MHansen, BEJeng, WJJanssen, HLY
2021
 
Differential relapse patterns after discontinuation of entecavir vs tenofovir disoproxil fumarate in chronic hepatitis B
Journal:Clinical Gastroenterology and Hepatology
Choi, HSHirode, GChen, CHSu, THSeto, WKWVen Hees, SPapatheodoridi, MLens, SWong, GLBrakenhoff, SMChien, RNFeld, JJSonneveld, MJChan, HLForns, XPapatheodoridis, GVVanwolleghem, TYuen, RMFHsu, YCKao, JHCornberg, MHansen, BEJeng, WJJanssen, HL
2022
 
Earlier and more frequent virological and clinical relapse after cessation of tenofovir disoproxil fumarate versus entecavir therapy: Results from a large, global, multi-ethnic cohort of chronic hepatitis B patients (RETRACT-B study)
Proceeding/Conference:Journal of Hepatology
Choi, HSJHirode, GChen, CHSu, THWong, GLHSeto, WKWHees, SVPapatheodoridi, MBrakenhoff, SLens, SSarowar, AChien, RNFeld, JForns, XSonneveld, MPapatheodoridis, GVanwolleghem, TYuen, RMFChan, HKao, JHHsu, YCCornberg, MHansen, BJeng, RWJJanssen, H
2021
 
HBsAg loss after nucleo(s)tide analogue withdrawal: relationship with viral antigen levels and hbv genotype
Proceeding/Conference:Poster presentation at the AASLD The Liver Meeting, November 12-15. 2021. Hepatology
Sonneveld, MJChiu, S-MPark, JYKaewdech, ASeto, WKWTanaka, YCarey, IPapatheodoridi, MVan Bömmel, FBrakenhoff, SBerg, TZoulim, FAhn, SHDalekos, GNErler, NSZu Siederdissen, CNWedemeyer, HCornberg, MYuen, RMFAgarwal, KBoonstra, AButi, MPiratvisuth, TPapatheodoridis, GChen, CHMaasoumy, BCREATE study group,
2021
 
HBsAg loss is higher among caucasians compared to Asians after stopping nucleos(t)ide analogue therapy: results from a large, global, multi-ethnic cohort of patients with chronic hepatitis B (RETRACT-B study)
Proceeding/Conference:Hepatology
Hirode, GChoi, HSJSu, THWong, GLHSeto, WKWHees, SVPapatheodoridi, MBrakenhoff, SLens, SSarowar, AChien, RNForns, XSonneveld, MJPapatheodoridis, GVanwolleghem, TYuen, RMFChan, HLYKao, JHHsu, YCChen, CHHansen, BECornberg, MJeng, WJJanssen, HLARETRACT-B Study Group,
2020
 
HBV DNA AND HBSAG LEVELS AT 24 WEEKS OFF-TREATMENT PREDICT CLINICAL RELAPSE AND HBSAG LOSS IN HBEAG NEGATIVE PATIENTS WHO DISCONTINUED ANTIVIRAL THERAPY
Journal:Gastroenterology
Sonneveld, MJChiu, S-MPark, JYBrakenhoff, SMKaewdech, ASeto, WKTanaka, YCarey, IPapatheodoridi, MColombatto, PVan Bömmel, FJanssen, HLBerg, TZoulim, FAhn, SHDalekos, GNErler, NSBrunetto, MWedemeyer, HCornberg, MYuen, MFAgarwal, KBoonstra, AButi, MPiratvisuth, TPapatheodoridis, GChen, C-HMaasoumy, B
26-Sep-2023
 
Hepatic decompensation and hepatocellular carcinoma after stopping nucleos (t)ide analogue therapy: Results from a large, global, multi-ethnic cohort of patients with chronic hepatitis B (RETRACT-B study)
Proceeding/Conference:Journal of Hepatology
Hirode, GHansen, BChen, CHSu, THWong, GLHSeto, WKWHees, SVPapatheodoridi, MBrakenhoff, SLens, XChoi, HSJChien, RNFeld, JForns, XSonneveld, MPapatheodoridis, GVanwolleghem, TYuen, RMFChan, HKao, JHHsu, YCCornberg, MJeng, RWJJassen, H
2021
 
Higher rates of virological relapse after nucleos (t)ide analogue withdrawal in HBeAg-negative versus positive chronic hepatitis B patients: results from a global, multi-ethnic cohort of patients with chronic hepatitis B (RETRACT-B Study). Poster Presentation (SAT415)
Proceeding/Conference:The International Liver Congress 2022, 22-26 June 2022. Journal of Hepatology
Choi, HSJHirode, GChen, C-HSu, T-HPapatheodoridi, MLens, SHees, SVBrakenhoff, SChien, R-NSeto, WKWWong, GFeld, JChan, HLYYuen, RMFSonneveld, MVanwolleghem, TForns, XPapatheodoridis, GKao, J-HHsu, Y-CCornberg, MHansen, BJeng, R W-JJanssen, H
2022
 
Incidence of hepatic decompensation after nucleos(t)ide analogue withdrawal: Results from a large, international, multi-ethnic cohort of patients with chronic hepatitis B (RETRACT-B study)
Journal:American Journal of Gastroenterology
Hirode, GHansen, BEChen, CHSu, THWong, GLSeto, WKWVan Hees, SPapatheodoridi, MBrakenhott, SMLens, SChoi, HSChien, RNFeld, JForns, XSonnevel, MJPapatheodoridis, GVVanwolleghem, TYuen, RMFChan, HLKao, JHHsu, YCCornberg, MJeng, WJJanssen, HL
2023
 
Low HBcrAg and HBsAg levels identify patients most likely to achieve sustained response after nucleos(t)ide analogue cessation: results from a global individual patient data meta-analysis (create study)
Proceeding/Conference:Journal of Hepatology
Sonneveld, MPark, JYSeto, WKWTanaka, YCarey, IPapatheodoridi, MZoulim, FAhn, SHDalekos, GHoener zu Siederdissen, CCornberg, MYuen, RMFAgarwal, KBoonstra, AButi, MPapatheodoridis, GMaasoumy, B
2020
 
Lower Pre-Treatment HBV DNA Levels Are Associated With Better Off-Treatment Outcomes After Nucleo(S)Tide Analogue Withdrawal In Patients With Chronic Hepatitis B
Proceeding/Conference:Hepatology
Sonneveld, MJChiu, SMPark, JYBrakenhoff, SKaewdech, ASeto, WKTanaka, YCarey, IPapatheodoridi, MColombatto, PVan Bommel, FBerg, TZoulim, FAhn, SHDalekos, GNErler, NSBrunetto, MWedemeyer, HCornberg, MYuen, MFAgarwal, KBoonstra, AButi, MPiratvisuth, TPapatheodoridis, GVChen, CHMaasoumy, B
31-Oct-2022
 
Nucleos(t)ide analogue withdrawal in chronic hepatitis B patients leads to limited sustained remission in the absence of HBsAg loss: results from the RETRACT-B study. Oral Presentation.
Proceeding/Conference:The Liver Meeting 2021 (AASLD 2021), 12-15 November 2021. Hepatology
Hirode, GHansen, BEChen, C-HSu, T-HPapatheodoridi, MLens, SHees, SVBrakenhoff, SChoi, HSJChien, RNSeto, WKWWong, GLHFeld, JJChan, HLYYuen, RMFSonneveld, MJVanwolleghem, TForns, XPapatheodoridis, GKao, J-HHsu, Y-CCornberg, MCornberg, W-JJanssen, HLARETRACT-B Study Group,
2021
 
Prediction Of Sustained Response After Nucleo(s)tide Analogue Cessation Using Hbsag And Hbcrag Levels – A Multicenter Study (create)
Journal:Clinical Gastroenterology and Hepatology
Sonneveld, MJPark, JYKaewdech, ASeto, WKTanaka, YCarey, IPapatheodoridi, Mvan Bommel, FBerg, TZoulim, FAhn, SHDalekos, GNErler, NSHoner zu Siederdissen, CWedemeyer, HCornberg, MYuen, MFAgarwal, KBoonstra, AButi, MPiratvisuth, TPapatheodoridis, GMaasoumy, B
2020
 
Predictors of HBsAg loss after cessation of nucleo (s)tide analogue therapy in asian patients with low HBsAg levels. Poster Presentation (SAT344)
Proceeding/Conference:The International Liver Congress 2022, 22-26 June 2022. Journal of Hepatology
Sonneveld1, MChiu, SMPark, JYKaewdech, ASeto, WKWTanaka, YCarey, IPapatheodoridi, Mvan Bömmel, FBrakenhoff, SBerg, TZoulim, FAhn, SHDalekos, GErler, NHoener zu Siederdissen, CWedemeyer1, HCornberg, MYuen, RMFAgarwa, KBoonstra, AButi, MPiratvisuth, TPapatheodoridis8, GChen, C-HMaasoumy, B
2022
 
Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levels
Journal:Journal of Hepatology
Sonneveld, MJChiu, SMPark, JYBrakenhoff, SMKaewdech, ASeto, WKWTanaka, YCarey, IPapatheodoridi, Mvan Bommel, FBerg, TZoulim, FAhn, SHDalekos, GSErler, NSHoner zu Siederdissen, CWedemeyer, HCornberg, MYuen, RMFAgarwal, KBoonstra, AButi, MPiratvisuth, TPapatheodoridis, GChen, CHMaasoumy, B
2022
 
Update of the statements on biology and clinical impact of occult hepatitis B virus infection
Journal:Journal of Hepatology
Raimondo, GLocarnini, SPollicino, TLevrero, MZoulim, FLok, ASAllain, JPBerg, TBertoletti, ABrunetto, MRBruno, RChen, DSCoppola, NCornberg, MCraxì, ADandri, MDi Marco, VFerrari, CGaeta, GBGlebe, DGuidotti, LGKramvis, ALampertico, PLi, CLiang, JMarzano, AMichalak, TIPawlotsky, JMPrati, DPuoti, MSamuel, DSoriano, VSquadrito, GSureau, CTrepo, CYuen, MF
2019
 
Viral and ALT kinetics after nucleos (t)ide analogue withdrawal among patients who remain off-therapy: results from a global, multi-ethnic cohort of chronic hepatitis B patients (RETRACT-B study). Poster Presentation (SAT400)
Proceeding/Conference:The International Liver Congress 2022, 22-26 June 2022. Journal of Hepatology
Hirode, GHansen, BChen, C-HSu, T-HPapatheodoridi, MLens, SHees, SVBrakenhoff, SChoi, SHJChien, R-NSeto, WKWWong, GFeld, JChan, HLYYuen, RMFSonneveld, MVanwolleghem, TForns, XPapatheodoridis, GKao, J-HHsu, Y-CCornberg, MJeng, R W-JJanssen, H
2022
Showing results 1 to 18 of 18